vor 5 Jahren

Novavax-Aktie: Vollständige Zulassung des Corona-Impfstoffs noch 2022 erwartet

Der US-Pharmakonzern Novavax rechnet noch in diesem Jahr mit der vollständigen Zulassung seines Totimpfstoffs gegen Covid-19. Unsere Einschätzung, was die Aktie macht.

Quelle: Börse Online RSS Feed

Blockchain.com Scammed me out of $27,000 USDvor 4 Stunden
Bag holders getting wrecked hard af , will be the longest bear season to date you hear here 1stvor 5 Stunden
⚡ Lightning Thursday! October 22, 2026: Explore the Lightning Network!⚡vor 6 Stunden
Daily Discussion, October 22, 2026vor 7 Stunden
Apparently a Class Action Lawsuit has been Filed against CoinKite, the Makers of ColdCard, for their Entropy-less Bug that cost users $116 Millionvor 12 Stunden
BTC资金回来了，趋势确认了吗？vor 12 Stunden
[ Removed by Reddit ]vor 12 Stunden
How do you keep a small BTC perps loss from turning into a bigger one?vor 12 Stunden
[ Removed by Reddit ]vor 14 Stunden
Why do people think Bitcoin can replace currency?vor 14 Stunden